Evidence map›Paper›PMID 30482943›Full record

ReviewNature cell biology2018

Tumour heterogeneity and metastasis at single-cell resolution.

Devon A Lawson, Kai Kessenbrock, Ryan T Davis, Nicholas Pervolarakis, Zena Werb

Abstract readReview
In one paragraph

Review in Nature cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 329 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
329citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

329 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

269 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Devon A LawsonDepartment of Physiology and Biophysics, University of California, Irvine, CA, USA. dalawson@uci.edu.ORCID http://orcid.org/0000-0003-1692-0517
Kai KessenbrockChao Family Comprehensive Cancer Center, University of California, Irvine, CA, USA. kai.kessenbrock@uci.edu.ORCID http://orcid.org/0000-0003-0410-6104
Ryan T DavisDepartment of Physiology and Biophysics, University of California, Irvine, CA, USA.
Nicholas PervolarakisDepartment of Biological Chemistry, University of California, Irvine, CA, USA.
Zena WerbDepartment of Anatomy, and Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Funding

Shared Resource Core: Single Cell AnalysisU54CA217378 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI VAN ETTEN, RICHARD A. · 2018 to 2022
$9.7M
CARCINOGENESIST32CA009054 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDINGER, AIMEE L, FRUMAN, DAVID ALEXANDER · 1985 to 2025
$8.6M
Integrative approach to heterogeneity in breast cancer metastasisU01CA199315 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI, SPELLMAN, PAUL T. · 2016 to 2020
$3.2M
Mathematical, Computational and Systems BiologyT32EB009418 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI LANDER, ARTHUR D, NIE, QING · 2009 to 2019
$2.4M
Proteolytic regulation of Wnt signaling in breast cancer stem cellsR00CA181490 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KESSENBROCK, KAI · 2016 to 2018
$730k
Single-cell analysis of intratumor heterogeneity in metastasisK22CA190511 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAWSON, DEVON A. · 2016 to 2018
$486k
NCI NIH HHS K22 CA190511NCI NIH HHS R00 CA181490NCI NIH HHS T32 CA009054NCI NIH HHS U01 CA199315NCI NIH HHS U54 CA217378NIBIB NIH HHS T32 EB009418
6 · The paper itself

Abstract

Tumours comprise a heterogeneous collection of cells with distinct genetic and phenotypic properties that can differentially promote progression, metastasis and drug resistance. Emerging single-cell technologies provide a new opportunity to profile individual cells within tumours and investigate what roles they play in these processes. This Review discusses key technological considerations for single-cell studies in cancer, new findings using single-cell technologies and critical open questions for future applications.

Indexed as

Genetic HeterogeneityBiomarkers, TumorGene Expression Regulation, NeoplasticHumansNeoplasm MetastasisNeoplasmsNeoplastic Cells, CirculatingSingle-Cell AnalysisTumor MicroenvironmentBiomarkers, Tumor

Identifiers

PMID30482943
PMCPMC6477686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.